Lexaria Bioscience (LEXX) Assets Growth (3y) (2017 - 2026)
Lexaria Bioscience (LEXX) Assets Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
62.26% |
| Nov 30, 2025 |
271.41% |
| Aug 31, 2025 |
-18.92% |
| May 31, 2025 |
-9.64% |
| Feb 28, 2025 |
-8.73% |
| Nov 30, 2024 |
-5.88% |
| Aug 31, 2024 |
-12.57% |
| May 31, 2024 |
-3.92% |
| Feb 29, 2024 |
-22.63% |
| Nov 30, 2023 |
-60.64% |
| Aug 31, 2023 |
2.93% |
| May 31, 2023 |
-72.68% |
| Feb 28, 2023 |
-8.56% |
| Nov 30, 2022 |
-64.96% |
| Aug 31, 2022 |
43.07% |
| May 31, 2022 |
38.26% |
| Feb 28, 2022 |
38.75% |
| Nov 30, 2021 |
49.09% |
| Aug 31, 2021 |
76.04% |
| May 31, 2021 |
57.32% |
